The Ethical Imperative And Moral Challenges Of Engaging Patients And The Public With Evidence
Open Access
- 1 April 2016
- journal article
- review article
- Published by Health Affairs Publishing, LLC in Health Affairs
- Vol. 35 (4) , 583-589
Abstract
Engaging patients and the public with evidence is an ethical imperative because engagement is central to respect for persons and will likely improve health outcomes, facilitate the stewardship of resources, enhance prospects for justice, and build public trust. However, patient and public engagement is also morally complex, because evidence alone is never definitive. As patients and the public engage with evidence, value conflicts will arise and must be managed to achieve trustworthy decision making. We outline value conflicts likely to emerge in the following five settings: clinical care, health care organizations, public health, the regulatory context, and among payers. Using a variety of examples, we offer suggestions about how such conflicts may be managed, including providing more opportunities for democratic deliberation and having more explicit community discussion of how to balance personal choice and community well-being, transparent discussions of cost and quality outcomes, and greater patient engagement in community-based participatory research and the governance of learning health systems.Keywords
This publication has 21 references indexed in Scilit:
- Twenty years and still counting: including women as participants and studying sex and gender in biomedical researchBMC Women's Health, 2015
- FDA Decisions and Public Deliberation:Challenges and OpportunitiesPublic Administration Review, 2013
- The Hastings Center Guidelines for Decisions on Life-Sustaining Treatment and Care Near the End of Life2013
- Choosing WiselyJAMA, 2012
- Building capacity for evidence informed decision making in public health: a case study of organizational changeBMC Public Health, 2012
- Moving Comparative Effectiveness Research Into Practice: Implementation Science And The Role Of Academic MedicineHealth Affairs, 2010
- The Ethical Urgency of Advancing Implementation ScienceThe American Journal of Bioethics, 2010
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion QuestionJNCI: Journal of the National Cancer Institute, 2009
- Public-sector health-care reforms that work? A case study of the US Veterans Health AdministrationThe Lancet, 2008
- RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 1998